Business Wire

Backlight to Showcase Product Line Innovations Across Creative and Streaming Workflows at IBC 2023

7.9.2023 18:50:00 EEST | Business Wire | Press release

Share

Global media and entertainment technology company Backlight announced that it is returning to the International Broadcasting Convention (IBC) this month with many new product updates and integrations to share with the industry. Backlight will be at booth 1.D09 to showcase innovative solutions that improve the video content lifecycle for broadcasters, content creators, publishers and distributors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230907741048/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Global media and entertainment technology company Backlight will showcase its feature-rich solutions that reduce pain points across the video lifecycle for more streamlined production and monetization at the 2023 International Broadcasting Convention (IBC). (Graphic: Business Wire)

Request a meeting with Backlight at IBC here.

Backlight Product Updates and Integrations

Backlight’s feature-rich solutions allow broadcasters and rights owners to create more content, distribute everywhere, unlock new revenue streams, and manage media and creative projects in the cloud intelligently and economically. The latest updates to its products to reduce pain points across the video lifecycle for more streamlined production and monetization include:

  • Wildmoka Live Studio: Backlight’s new digital-first live production platform. Backlight will demonstrate how Live Studio’s single interface makes it easy to tailor an existing live stream, or create a new one, from multiple live sources, clips, graphics and images, while preserving brand consistency with pre-configured production rooms and templated destinations. With the browser-based Live Studio, customers quickly generate platform-specific, low-latency content experiences and engage broader audiences through simultaneous distribution to any digital destination.
  • AI-assisted inventory creation within Zype Playout. Backlight’s ability to detect ad opportunities using machine learning is combined with low latency ad routing, device targeting, and a custom approach to ad macros in the newest version of Zype Playout. Customers have seen 516% increases in ad inventory, 15% increases in fill rate and 44% improvements in ad rendering when compared to leading playout providers.
  • Asset management, cloud production and content distribution – simplified. Backlight will showcase how easy it is to pull assets from any storage managed by iconik into Wildmoka’s live production environment for hyperdistribution as well as workflows for metadata-intelligent live-to-archive.
    • Add media management, review and collaboration to live media management workflows and scale up in the cloud for key events.
    • Push clips or archived content from Wildmoka to iconik for long-term storage, quick discovery, and reutilization in marketing initiatives – all in a browser.
  • New features and integrations for iconik, ftrack and cineSync increase creative workflow speed, flexibility and control.
    • iconik’s Favoriting functionality allows quicker retrieval of key assets, and updates to Collections now provide detailed insights into their sizes and creation history to empower better storage decision-making and resource allocation.
    • iconik demos will include a forthcoming integration with Apple's Final Cut Pro X that empowers users to effortlessly import/export iconik media directly into their FCPX editing environment and an updated integration with the powerful media review and approval solution cineSync.
    • cineSync expands format and standards support with OTIOZ playback, USD support and new ways to manage colors and notes in cineSync 5
    • ftrack Studio offers next-level precision for creative reviews by adding Wacom and stylus support and increased control for production tracking with new task scheduling and notification options.

Backlight’s Leaders to Share Insights on Monetizing Content and Remote Production

Leaders from Backlight will participate in two thought leadership forums at IBC—the SVG Sport Production Summit and the DPP Espresso Summit:

SVG Europe Sport Production Summit | Thursday, September 14, 2023 at 15:05 CET

  • Christophe Messa, Backlight’s director of Strategic Partners will join panelists from Tinkerlist, Spiideo, and Vislink for a discussion on Making and Monetizing Sports Content at the SVG Europe Sports Production Summit. Attendees will learn about best practices and new strategies that right owners are using to generate income for sports content, including on social media, OTT platforms and apps.

DPP Espresso Summit | Friday, September 15, 2023 at 0930 CET

  • At this breakfast briefing hosted by DPP, Backlight Chief Product Officer, Mike Szumlinski and other panelists will discuss hybrid working and the technology needed to support remote production more broadly.

Backlight is Shortlisted for Three Awards at IBC

  • The International Trade Association for the Broadcast & Media Industry (IABM) has shortlisted Backlight’s media management platform, iconik, for a BaM award in the Manage category. Iconik revolutionizes how organizations of all sizes manage, share and collaborate on digital assets.
  • Backlight’s Zype Apps Creator solution was shortlisted for an award by CSI Magazine in the Best VoD or content-on-demand solution category. Zype Apps Creator is Backlight’s turnkey solution for building streaming apps to deliver and monetize branded experiences across owned and operated and popular third-party platforms.
  • Backlight has been shortlisted for a Corporate Star award for Best Charity/CSR initiative for its collaboration with HUFO, a student-led film organization at Howard University that provides students with the resources they need to launch and leverage careers within the entertainment industry.

About Backlight

Backlight is a global media technology company that dramatically improves every stage of the video and entertainment content lifecycle, from creation through monetization. Backed by $200M in funding from PSG, Backlight has acquired six leading media software companies since launching in 2021. Video-forward organizations solve their mission-critical business and operational challenges by partnering with Backlight’s two divisions: Backlight Creative and Backlight Streaming. Backlight Creative provides award-winning software solutions for secure and efficient media management, production tracking and creative collaboration, including iconik, ftrack, Gem and Celtx. Backlight Streaming provides cloud-based OTT video streaming, content management, media production, hyperdistribution, and monetization software, including Zype and Wildmoka, to the world’s most innovative publishers and broadcasters. For more information visit backlight.co.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Bubble Agency for Backlight | backlight@bubbleagency.com
Backlight | media@backlight.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye